Manufactures pharmaceutical products and formulations. Revenue comes from B2B and retail distribution. Focuses on quality, regulatory compliance, and research. Operates manufacturing-led pharmaceutical model.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.
Sign in to see dividends, bonuses and splits - free.
Sign in